{
    "2021-07-10": [
        [
            {
                "time": "",
                "original_text": "同质化创新受打击，药明康德震荡，贝达药业跌跌不休「基因测序周评榜」",
                "features": {
                    "keywords": [
                        "同质化创新",
                        "药明康德",
                        "贝达药业",
                        "基因测序"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "基因测序"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}